Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has floated a tender for Notice of Intent to Sole Source - Aptamer Library Generation Services for USAMRIID. The project location is USA and the tender is closing on 06 Feb 2025. The tender notice number is HT942525R0028, while the TOT Ref Number is 113671125. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Notice of Intent to Sole Source - Aptamer Library Generation Services for USAMRIID
Deadline : 06 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 113671125
Document Ref. No. : HT942525R0028
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a Firm Fixed Price, sole source, contract on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Aptagen, LLC located at 250 N Main Street, Jacobus, PA 17407, under the authority as prescribed in FAR 13.501 (a) (1) ( ii), sole source (including brand name) under the authority of simplified procedures for certain commercial items.
This new requirement is for the need to generate two (2) Deoxyribonucleic Acid (DNA) Aptamer Library Generation per anticipated projects per year. These aptamer libraries will consist of
1000 -
10, 000 targeted aptamers. These libraries will target specific alpha-conotoxins and palytoxins and should be capable of broad-spectrum interactions and libraries targeting four (4) to six (6) viral targets. This new requirement was identified to support USAMRIID-s project NB38075, Development of broad-spectrum DNA aptamers to neutralize toxins.
Aptagen LLC is the only vendor capable of providing reagents that can be used on site to initiate the process, train in their use, and then synthesize and characterize the aptamers that are promising candidates. Aptagen, LLC is a leader in aptamer library generation. Aptagen owns its proprietary processes of aptamer development. They are the only company to provide aptamer library kits along with library characterization services. Further, Aptagen LLC provides the ability for USAMRIID to leverage its expertise while retaining possession of the select agent in accordance with USAMRIID-s strict and rigorous access and control protocols, allowing for the production of the libraries within said containment parameters.
This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail ...
Active Contract Opportunity
Notice ID : HT942525R0028
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: ARMY MED RES ACQ ACTIVITY
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Jan 23, 2025 03:57 pm EST
Original Response Date: Feb 06, 2025 01:00 pm EST
Inactive Policy: Manual
Original Inactive Date: Mar 06, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN22 - HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: MD 21702 USA
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google